Showing posts with label Comments from Michael Rogers to FDA Draft Guidance Re: 503A. Show all posts
Showing posts with label Comments from Michael Rogers to FDA Draft Guidance Re: 503A. Show all posts

Saturday, February 8, 2014

Comments from Michael Rogers to FDA Draft Guidance Re: 503A

Comment from Michael Rogers

  • Although I understand that compounding pharmacies cannot compound replicas of drugs on the market I think a exception should be made if there is a true need where the patient...

  • Public Submission
  • Posted:
    01/13/2014
  • ID:
    FDA-2013-D-1444-0003